Kennedy Lewis GP III LLC
CIK: 0001897209
Associated companies
Transaction History
| DOUG | ▲ Buy | Grant | 61,983 | $0 | 6/28/2025 | View on chart |
| DOUG | ▲ Buy | Grant | 61,983 | $0 | 6/28/2025 | View on chart |
| DOUG | ▲ Buy | Grant | 58,975 | $0 | 7/31/2024 | View on chart |
| DOUG | ▲ Buy | Grant | 58,975 | $0 | 7/31/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Citizens Begins Coverage of Douglas Elliman with Market Perform Rating
Citizens has started a research report on Douglas Elliman and assigned a Market Perform rating. The rating suggests a neutral outlook for the stock. The coverage may increase analyst attention and provide new information for investors. The stock is currently trading near its 52‑week low and shows a moderate RSI, indicating room for movement.
Citizens Begins Coverage of Douglas Elliman with Market Perform Rating. Citizens has started a research report on Douglas Elliman and assigned a Market Perform rating. The rating suggests a neutral outlook for the stock. The coverage may increase analyst attention and provide new information for investors. The stock is currently trading near its 52‑week low and shows a moderate RSI, indicating room for movement.